Frequently Asked Questions (FAQ’s) about Follistatin 344 Peptide Image of Defined Muscle
Buy Follistatin 344 Pre-Mixed Pen America for research. Choose between individual cartridges or a Pen Kit that includes a pre-mixed cartridge with bacteriostatic water, a peptide pen with a carry case, and three needle tips.
Does Follistatin 344 have any side effects?
Like many bioactive substances, it may have side effects, especially with limited research on its long-term use. Excessive or improper use could lead to muscle imbalances, joint strain, and hormonal disruptions. Other possible side effects include fatigue, headaches, or gastrointestinal discomfort, varying by individual. Since its safety is not fully established, professional medical supervision is essential for any use.
Is Follistatin 344 legal?
The legality varies depending on the country and its intended use. For instance, in the USA, the Food and Drug Administration (FDA) has not approved it for medical or commercial use. Similarly, in the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) strictly regulates substances like peptides, limiting their use exclusively to approved research settings. It is essential to consult local America regulations and fully understand the legal implications before deciding to buy Follistatin 344 for any purpose.
Can Follistatin 344 treat any medical conditions?
Early America studies suggest that it may have therapeutic potential for muscle-wasting diseases, certain cancers, and metabolic conditions. However, more studies and clinical trials are necessary to verify these applications.
What is the difference between Follistatin 344 and ACE-031?
Follistatin 344 and ACE-031 are both associated with muscle growth, but they function in different ways. FST 344 is a naturally occurring protein that binds to and inhibits myostatin, a growth differentiation factor that regulates muscle growth. By suppressing myostatin, it can promote increased muscle mass.
ACE-031, on the other hand, is a synthetic protein designed to mimic the effects of blocking myostatin. It acts as a soluble activin receptor type IIB (ActRIIB), which binds not only to myostatin but also to other related growth factors, thereby enhancing its muscle-building potential.
While both are experimental therapies with similar goals, their methods of action and scope of inhibition differ, impacting their effectiveness and safety profiles.
Buy Follistatin 344 Peptide Today!
Buy Follistatin 344 peptide America from Direct Sarms, your trusted source for 99% pure, research-grade peptides. Available in various formats, including lyophilized powder (1mg vial), 15ml and 30ml nasal sprays, and 1mg pre-mixed pens for convenience. Made for laboratory purposes, this peptide ensures exceptional purity and quality for accurate research results.
Scientific References
(1) Benjamin C. Yaden, Johnny E. Croy, Yan Wang, Jonathan M. Wilson, et al (2014) Follistatin: A Novel Therapeutic for the Improvement of Muscle Regenerations – The Journal of Pharmacology and Experimental Therapeutics, Volume 349, Issue 2, May 2014, Pages 355-371.
(2) Jerry R Mendell, Zarife Sahenk, Vinod Malik, Ana M Gomez, et al (2015) A Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy – Molecular Therapy, Volume 23, Issue 1, January 2015, Pages 192-201.
(3) Max D Knickmeyer, Juan L Mateo, Priska Eckert, Eleni Roussa, Belal Rahhal, et al (2018) TGFβ-facilitated optic fissure fusion and the role of bone morphogenetic protein antagonism – Open Biology, 2018 Mar, Volume 8 (Issue 3), Page 170134.
(4) Caroline Barbé, Stéphanie Kalista, Audrey Loumaye, Olli Ritvos, Pascale Lause, et al (2015) Role of IGF-I in follistatin-induced skeletal muscle hypertrophy – American Journal of Physiology, Endocrinology & Metabolism, 2015 Sep 15, Volume 309 (Issue 6), Pages E557-67.
(5) Andrea Iskenderian, Nan Liu, Qingwei Deng, Yan Huang, Chuan Shen, et al (2018) Myostatin and activin blockade by engineered follistatin results in hypertrophy and improves dystrophic pathology in mdx mouse more than myostatin blockade alone – Skeletal Muscle, 2018 Oct 27, Volume 8 (Issue 1), Page 34.
(6) Louise R Rodino-Klapac, Amanda M Haidet, Janaiah Kota, Chalonda Handy, et al (2009) Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease – Muscle & Nerve, 2009 Mar, Volume 39 (Issue 3), Pages 283-96.
(7) S Muttukrishna, A Farouk, S Sharma, L Evans, et al (2001) Serum activin A and follistatin in disorders of spermatogenesis in men – European Journal of Endocrinology, 2001 Apr, Volume 144 (Issue 4), Pages 425-9.
(8) Michael P Zimber 1, Craig Ziering, Fraink Zeigler, Mark Hubka, et al (2011) Hair regrowth following a Wnt- and follistatin containing treatment: safety and efficacy in a first-in-man phase 1 clinical trial – Journal of Drugs in Dermatology, 2011 Nov, Volume 10 (Issue 11), Pages 1308-12.
(9) Chunxia Zhao, Chunping Qiao, Ru-Hang Tang, Jiangang Jiang, et al (2015) Overcoming Insulin Insufficiency by Forced Follistatin Expression in β-cells of db/db Mice – Molecular Therapy, 2015 May, Volume 23 (Issue 5), Pages 866-874.
(10) Catherine Zabkiewicz, Jeyna Resaul, Rachel Hargest, Wen Guo Jiang, and Lin Ye (2017) Increased Expression of Follistatin in Breast Cancer Reduces Invasiveness and Clinically Correlates with Better Survival – Cancer Genomics & Proteomics, 2017 Jul-Aug, Volume 14 (Issue 4), Pages 241-251.
(11) Marco Chi-Chung Lau, Kai Yu Ng, Tin Lok Wong, Man Tong, et al (2017) FSTL1 Promotes Metastasis and Chemoresistance in Esophageal Squamous Cell Carcinoma through NFκB-BMP Signaling Cross-talk – Cancer Research, 2017 Nov 1, Volume 77 (Issue 21), Pages 5886-5899.
ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.
DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our Direct Sarms website is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.